Clinical efficacy of clozapine in treatment-refractory schizophrenic patients

By Min-Soo L.   In-Kwa J.   Dong-Il K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 342-342

Elsevier

Access to resources Recommend Favorite

Dual Diagnosis and Quality of Life in Patients in Treatment for Opioid Dependence

By Bizzarri Jacopo   Rucci Paola   Vallotta Alessia   Girelli Massimo   Scandolari Anna   Zerbetto Elisabetta   Sbrana Alfredo   Iagher Claudia   Dellantonio Elio  

Substance Use & Misuse, Vol. 40, Iss. 12, 2005-11 ,pp. : 1765-1776

Informa Healthcare

Access to resources Recommend Favorite

Effects of clozapine on plasma monoamine metabolites in treatment-refractory schizophrenic patients

By Min-Soo L.   Seung-Hyun K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 341-342

Elsevier

Access to resources Recommend Favorite

Rehabilitation of Schizophrenic Patients

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2277-2288

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals

By Ruiu Stefania   Casu Maria Antonietta   Casu Gianluca   Piras Sara   Marchese Giorgio  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. : 1631-1643

Informa Healthcare

Access to resources Recommend Favorite